AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 8th, 2020 • Ocugen, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 8th, 2020 Company Industry JurisdictionTHIS AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), is made as of January 1, 2020 (the “Effective Date”) by and between Ocugen, Inc., a Delaware corporation (the “Company”), and Kelly A. Beck, an individual (“Employee”).
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 8th, 2020 • Ocugen, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMay 8th, 2020 Company IndustryTHIS AMENDMENT (this “ Amendment”), dated as of January l, 2020 is made by and between Ocugen, Inc. (the “Company”) and Sanjay Subramanian (the “Executive”).